Evidence map›Paper›PMID 40604992›Full record

ArticleBMC proceedings2025

Urinary tract infection in adults: gaps in current guidelines - opinions from an international multidisciplinary panel and relevance to clinical practice.

Kalpana Gupta, Florian Wagenlehner, Mark Wilcox, Sonali D Advani, Manu Bilsen, Gernot Bonkat, Rafael Cantón, Suzanne Geerlings, Beatrice Grabein, Juan P Horcajada and 3 more

Abstract read
In one paragraph

Article in BMC proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Postbiotic approach to antibiotic resistance: antibacterial and antibiofilm potential of Lactobacillus salivarius supernatant.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  4. Shifting Antimicrobial Susceptibility Patterns of Uropathogens: A 20-Year Analysis of Urine Cultures.International journal of urology : official journal of the Japanese Urological Association · 2026
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kalpana Gupta *Boston University School of Medicine, Boston, USA.
Florian Wagenlehner *Clinic for Urology, Paediatric Urology and Andrology, Justus Liebig University, Giessen, Germany. florian.wagenlehner@chiru.med.uni-giessen.de.
Mark Wilcox *School of Medicine, Leeds Institute of Medical Research, University of Leeds & Leeds Teaching Hospitals, Leeds, UK.
Sonali D AdvaniViiV Healthcare, Durham, USA.
Manu BilsenDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Gernot BonkatAlta Uro AG, Merian Iselin Klinik, Center of Biomechanics & Calorimetry, University of Basel, Basel, Switzerland.
Rafael CantónServicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain and CIBER de Investigación en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Suzanne GeerlingsDepartment of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
Beatrice GrabeinStabsstelle Klinische Mikrobiologie und Krankenhaushygiene, LMU Klinikum, Munich, Germany.
Juan P HorcajadaInfectious Diseases Service, Hospital del Mar; Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Pamela KushnerDepartment of Family Medicine, University of California Irvine Medical Center, Orange, USA.
Navaneeth NarayananDepartment of Pharmacy Practice and Administration, Rutgers University Ernest Mario School of Pharmacy, Piscataway, USA.
Marc ScheetzDepartments of Pharmacy Practice and Pharmacology, Colleges of Pharmacy and Graduate Studies, Midwestern University, Downers Grove, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlthough urinary tract infections (UTIs) are one of the most common infections encountered in clinical practice, many challenges remain with respect to classification and management. The purpose of this report is to discuss key issues in the management of UTIs and identify gaps in current knowledge and guidelines, as well as future research needs.

designA multidisciplinary panel of 13 experts from 6 European countries and the United States met on April 27, 2024. They discussed predefined key clinical questions, including classification of UTIs, current management guidelines, management of UTIs in men, antimicrobial switching, and post-treatment asymptomatic bacteriuria.

resultsThe panel agreed that differentiation between complicated and uncomplicated UTIs is crucial to antimicrobial selection and can impact outcomes. In particular, definitions of complicated UTIs (cUTIs) vary widely between guidelines and in the literature. Patients with cUTIs are not a homogeneous group and differences in risk factors and prognosis should be considered. However, a balance must be sought between appropriate antimicrobial treatment and complexity of guidelines, which can hinder their implementation, especially in primary care. Guidelines published by the European Urology Association and the Infectious Diseases Society of America differ in their antimicrobial treatment recommendations for cUTIs, which is important at a time of increasing antimicrobial resistance. In men with UTIs, it has been established that a longer duration of antimicrobial therapy is needed in cases where fever is present. De-escalation from broad- to narrow-spectrum antimicrobials is recommended wherever possible, and is associated with similar outcomes in many patients relative to remaining on broad-spectrum treatment. Post-treatment asymptomatic bacteriuria should not be assessed, and treatment is not recommended. Non-specialist physician education is crucial to achieving better outcomes for patients with UTIs. IMPLICATIONS: Many challenges remain in the management of UTIs in adults, most notably making an accurate classification, which drives antimicrobial treatment selection. A balance between adequacy of management guidelines and their uptake in routine clinical practice is needed to improve outcomes.

Indexed as

Antimicrobial de-escalationAntimicrobial resistanceComplicated urinary tract infectionGuidelineUncomplicated urinary tract infection

Identifiers

PMID40604992
PMCPMC12224355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.